ITMCTR2100004581招募中2 期
A randomized, double-blind, parallel controlled, multi-center clinical trial of the effectiveness and safety of Qingke Pingchuan Granules in the treatment of children with acute bronchitis (phlegm-heat stagnation lung syndrome)
Shanghai Traditional Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 6 至 14(—)
- 性别
- All
入选标准
- •1. Meet the diagnostic criteria of western medicine for acute bronchitis in children;
- •2. TCM syndrome differentiation accords with phlegm-heat stagnation syndrome;
- •3. 6 years old <= age <= 14 years old, no gender limit;
- •4. Course of disease <= 48h;
- •5. Parents or guardians voluntarily agree and sign the informed consent form, and the children = 8 years old participate in the informed consent and sign the informed consent form.
排除标准
- •1. Severe bronchitis and pneumonia are difficult to distinguish in the early stage;
- •2. Suffer from acute infectious diseases such as measles, whooping cough and influenza;
- •3. Children with acute upper respiratory tract infection, bronchial asthma, bronchiolitis, bronchopneumonia and other respiratory diseases;
- •4. Children with acute attacks of chronic bronchitis;
- •5. The total number of white blood cells > 12 x 10^9/L, and the percentage of neutrophils > 70%;
- •6. Children with malnutrition and immunodeficiency;
- •7. Children whose body temperature exceeds 38.0 degrees C;
- •8. Liver function test values (ALT, AST) > upper limit of normal value, blood creatinine > upper limit of normal value;
- •9. Those who are allergic to the test drug or its components;
- •10. Children who have used antibiotics, cough-reducing and phlegm-resolving medicines and other Chinese and Western medicines that have an impact on cough within 24 hours before treatment;
- •11. Combined with serious primary diseases such as severe heart, liver, kidney, digestive and hematopoietic system;
- •12. According to the judgment of the investigator, there are other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as unstable living environment, inconvenient transportation, etc. that may easily cause loss to follow-up.
研究者
相似试验
尚未招募
4 期
A randomized, double-blind, parallel controlled, multicenter clinical trial for the efficacy and safety of Bairui granule in the treatment of acute upper respiratory tract infection (wind heat syndrome) in childreacute upper respiratory tract infection (wind heat syndrome) in childrenITMCTR2000003111Dongzhimen Hospital Beijing University of Chinese Medicine
尚未招募
不适用
A randomized, double-blind, parallel-controlled, multicenter trial to evaluate the effectiveness and safety of Xiyanping injection combined with azithromycin and azithromycin in the treatment of mycoplasma pneumoniae pneumonia in childreMycoplasma pneumoniae pneumoniaITMCTR2000003093The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
招募中
4 期
A randomized, double-blind, parallel-controlled, multi-center clinical trial of Chinese medicine variety protection with Niuhuang Qinggan Capsule in the treatment of common cold (wind-heat syndrome)Common cold (wind-heat syndrome)ITMCTR2200005537The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
招募中
4 期
A randomized, double-blind, parallel-controlled, multi-center clinical trial of traditional Chinese medicine variety protection with Wuhu Oral Liquid in the treatment of acute soft tissue injury (Qi stagnation and blood stasis syndrome)acute soft tissue injuryITMCTR2200005606onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
招募中
4 期
A randomized, double-blind, parallel-controlled, multicentre clinical study to evaluate the efficacy and safety of Sechang Zhixie Powder in the treatment of acute watery diarrhea in childreAcute watery diarrheaITMCTR2100004284First Teaching Hospital of Tianjin University of TCM
